Browse by Medical Category
Accepting New Patients
Go To Programs
MassGeneral Hospital for Children
Go To Specialties
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Virkud received her undergraduate degree at Harvard University in Biochemical Sciences, completed her medical training at Washington University in St. Louis, and concurrently obtained a Masters in Biology and Biomedical Sciences under the mentorship of Dr. John Constantino at Washington University. She completed her residency in pediatrics at St. Louis Children’s Hospital. She trained at Duke University for her fellowship in Allergy and Immnology, where she researched under the mentorship of Dr. Wesley Burks, exploring the safety of investigational therapies for food allergy. During this time, she also completed a clinical research fellowship at Duke Clinical Research Institute and a Masters of Public Health in Biostatistics at the University of North Carolina-Chapel Hill (UNC). She currently is a pediatric allergist/immunologist at Massachusetts General Hospital for Children, an instructor at Harvard Medical School, and an associate epidemiologist at the Channing Division of Network Medicine, Brigham & Women’s Hospital.
Dr. Virkud's research focuses on the phenotyping different patients with food allergy and understanding the mechanisms of investigational therapies for food allergy. Areas of active investigation include (1) safety of investigational therapies such as oral immunotherapy and predicting which patients are most likely to benefit, (2) studying metabolite and RNA profiles of patients with food allergy, (3) investigating non-IgE mediated disease, like cow's milk protein intolerance in collaboration with the Gastrointestinal Microbiome and Allergic Proctocolitis (GMAP) Study . She works with numerous collaborators including from the Consortium for Food Allergy Research , the Broad Insititute, other members of the MGHfC Food Allergy Center and the Channing Division of Network Medicine.
View my most recent publications at PubMed
Virkud YV, Burks AW, Steele PH, Edwards LJ, Berglund JP, Jones SM, Scurlock AM, Perry TT, Pesek RD, Vickery BP. Novel Baseline Predictors of Allergic Side Effects During Peanut Oral Immunotherapy. J Allergy Clin Immunol. 2016. Epub ahead of print. PMID 27609653.
Burk CM, Dellon ES, Steele PH, Virkud YV, Kulis M, Burks AW, Vickery BP. Eosinophilic esophagitis during peanut oral immunotherapy with omalizumab. J Allergy Clin Immunol Pract. 2016. PMID 28017628.
Vickery BP, Berglund JP, Burk CM, Fine JP, Kim EH, Kim JI, Keet CA, Kulis M, Orgel, KG, Guo R, Steel, PH, Virkud YV, Ye P, Wright BL, Wood RA, Burks AW. Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective. J Allergy Clin Immunol. 2017: 139(1):173-181. PMID: 27522159.
Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, Burk C, Hiegel A, Carlisle S, Christie L, Perry TT, Pesek RD, Sheikh S, Virkud Y, Smith PB, Shamji MH, Durham SR, Jones SM, Burks AW. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol. 2013; 133(2): 468-75. PMID: 24361082
Kelly RS, Virkud Y, Giorgio R, Celedón JC, Weiss ST, Lasky-Su J. Metabolomic profiling of lung function in Costa-Rican children with asthma. Biochim Biophys Acta. 2017; Epub ahead of print. PMID: 28188833
Virkud YV, Hornik CP, Benjamin DK, Laughon MM, Clark RH, Greenberg RG, Smith PB. Respiratory support for very low birth weight infants receiving dexamethasone. The Journal of Pediatrics. 2017. PMID: 28108103.
Growing up, Zach Leitao sometimes felt left out from social gatherings because of his severe food allergies. This past winter and spring, Zach, 8, recently passed food challenges, which means three of his previous food allergies are no longer a concern. Now the Leitaos feel more confident and safe knowing that Zach's world is open to a whole new set of culinary possibilities.
Back to Top